Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer immunotherapy
deals
2
×
fda
life sciences
national blog main
national top stories
new york blog main
2
×
san francisco blog main
acute myeloid leukemia
alx oncology
autoimmune diseases
berkeley lights
biotech ipos
boston
cancer
cancer drugs
cd47
center for medicare and medicaid services
chronic kidney disease
clinical trials
companion diagnostic
daniel o'day
deerfield healthcare technology acquisitions
deerfield management company
europe blog main
europe top stories
foundation medicine
foundationone cdx
foundationone heme
genentech
immunotherapy
investing
kidney disease
medicare
myelodysplastic syndrome (mds)
national
new york top stories
What
momentum
2
×
acquire
agreed
arrival
big
billion
biotech
broad
companies
confidence
days
didn’t
foundation
gain
genentech
hasn’t
industry
ipo
ipos
life
market
medicine
morning
new
panels
pay
pays
picked
profiling
raised
recently
redux
remaining
research
rest
roche
science
share
slowed
stock
Language
unset
Current search:
momentum
×
deals
×
" new york blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine